Gateway™ LR Clonase™ Enzyme mix
Product Image
Invitrogen™

Gateway™ LR Clonase™ Enzyme mix

Gateway® LR Clonase® II酵素ミックスにはInt(Integrase)、IHF(Integration Host Factor詳細を見る
製品番号(カタログ番号)数量
11791043100反応
1179101920反応
製品番号(カタログ番号) 11791043
価格(JPY)
304,500
Each
お問い合わせください ›
数量:
100反応
Gateway® LR Clonase® II酵素ミックスにはInt(Integrase)、IHF(Integration Host Factor)およびXis(Excisionase)タンパク質を含みます。エントリークローン(目的遺伝子の両末端にattL配列が付加されている)とデスティネーションベクター(attR配列を含む)の間でのin vitroの組換え反応を触媒し、発現クローン作製に使用されます。お客様のアプリケーション、ご希望のフォーマットに合わせ、さまざまなフォーマットのLR Clonase酵素ミックスをご用意しております。LR Clonase II Plus酵素ミックスは、最高の組換え効率を提供する最新バージョンで(表1)、単一フラグメントと複数フラグメントの両方のクローニングに特異的に最適化されています(表1)。LR Clonase II Plus酵素ミックスは、酵素と反応バッファーを最適化した一つのミックスで提供し、単一フラグメントと複数フラグメントの両方のクローニングに適した酵素の安定性と使いやすさを少ないピペット操作で実現します。当社のLRクロナーゼ II酵素ミックスは、単一のミックスフォーマットでもご利用いただけますが、オリジナルのLRクロナーゼ®酵素は、個別のチューブ入りの酵素とバッファーです
研究用にのみ使用できます。診断用には使用いただけません。
仕様
適合バッファー反応バッファー
製品タイプLRクロナーゼ酵素ミックス
数量100反応
出荷条件ドライアイス
酵素LRクロナーゼ
製品ラインClonase, Gateway
Unit SizeEach
組成および保存条件
すべてのGateway™ LRクロナーゼ™酵素キットには、プロテイナーゼK溶液(2 µg/µl)とポジティブコントロールベクターが含まれます。LRクロナーゼ™酵素は-80℃で保存し、LRクロナーゼ™IIまたはII Plus酵素混合物は-20℃で保存します。適切に保存した場合、6カ月間安定しています。

よくあるご質問(FAQ)

I performed an LR reaction and got high background after transformation. Can you please offer some troubleshooting tips?

– Check whether the reaction was transformed into an E.coli strain containing the F' episome and the ccdA gene – use an E.coli strain that does not contain the F&339; episome, e.g. OmniMAX 2-T1R, TOP10.
– Deletion (full or partial) of the ccdB gene – propagate in media with 50-100 mg/mL ampicillin and 15-30 µg/mL chloramphenicol.
– Contamination from another resistant strain.
– Check whether proper amount of DNA was used in the reaction.

I performed an LR reaction and got two distinct types of colonies (large and small) after transformation. What could be the possible reasons?

– Plasmid was lost during culture due to large size or toxicity – try incubating at 30 degrees C; use Stbl2 E.coli to stabilize the plasmid.
– Deletions (full or partial) or point mutations in the ccdB gene – obtain a new Destination vector.
– Small colonies may be unreacted entry clone that co-transforms with the Expression clone – reduce the amount of Entry clone to 50 ng per 10 µL reaction; reduce the volume of sample used for transformation to 1 µL; for a Destination vector with ampicillin selection marker, increase the ampicillin concentration to 300 µg/mL.

I performed an LR reaction and got no colonies after transformation, and the recombination positive control was not successful. Can you please offer some suggestions?

– Check the competent cells with pUC19 transformation.
– Increase the amount plated.

I performed an LR reaction and got few or no colonies after transformation, whereas the transformation control gave colonies. Can you please offer some suggestions?

– Increase the incubation time up to 18 hours.
– Make sure to treat reactions with proteinase K before transformation.
– Check whether the correct antibiotic was used for selection.
– Check whether the att site sequences are correct.
– Check whether the correct Clonase enzyme was used and whether it was functional.
– Check whether the recommended amount of DNA was used in the reaction.
– Perform the positive control recombination with pENTR-Gus plasmid.
– If the Entry clone or Destination vector is too large (>10 kb), incubate the LR reaction overnight, linearize the Destination vector or the Entry clone or relax the Destination vector with topoisomerase I.

Can I create a single Entry vector for use with DEST vectors that have N-terminal tags and C-terminal tags?

No, since a stop codon would be necessary for an N-terminal tagged destination vector, whereas the presence of a stop codon would block expression of the C-terminal tag.

引用および参考文献 (4)

引用および参考文献
Abstract
High-throughput yeast two-hybrid assays for large-scale protein interaction mapping.
Authors:Walhout AJ, Vidal M,
Journal:Methods
PubMed ID:11403578
'Protein-protein interactions play fundamental roles in many biological processes. Hence, protein interaction mapping is becoming a well-established functional genomics approach to generate functional annotations for predicted proteins that so far have remained uncharacterized. The yeast two-hybrid system is currently one of the most standardized protein interaction mapping techniques. Here, we ... More
Functional identification of Arabidopsis stress regulatory genes using the controlled cDNA overexpression system.
Authors:Papdi C, Abrahám E, Joseph MP, Popescu C, Koncz C, Szabados L,
Journal:Plant Physiol
PubMed ID:18441225
'Responses to environmental stresses in higher plants are controlled by a complex web of abscisic acid (ABA)-dependent and independent signaling pathways. To perform genetic screens for identification of novel Arabidopsis (Arabidopsis thaliana) loci involved in the control of abiotic stress responses, a complementary DNA (cDNA) expression library was created in ... More
Homologous high-throughput expression and purification of highly conserved E coli proteins.
Authors:Ergin A, Büssow K, Sieper J, Thiel A, Duchmann R, Adam T,
Journal:Microb Cell Fact
PubMed ID:17553160
BACKGROUND: Genetic factors and a dysregulated immune response towards commensal bacteria contribute to the pathogenesis of Inflammatory Bowel Disease (IBD). Animal models demonstrated that the normal intestinal flora is crucial for the development of intestinal inflammation. However, due to the complexity of the intestinal flora, it has been difficult to ... More
Human protein factory for converting the transcriptome into an in vitro-expressed proteome,.
Authors:Goshima N, Kawamura Y, Fukumoto A, Miura A, Honma R, Satoh R, Wakamatsu A, Yamamoto J, Kimura K, Nishikawa T, Andoh T, Iida Y, Ishikawa K, Ito E, Kagawa N, Kaminaga C, Kanehori K, Kawakami B, Kenmochi K, Kimura R, Kobayashi M, Kuroita T, Kuwayama H, Maruyama Y, Matsuo K, Minami K, Mitsubori M, Mori M, Morishita R, Murase A, Nishikawa A, Nishikawa S, Okamoto T, Sakagami N, Sakamoto Y, Sasaki Y, Seki T, Sono S, Sugiyama A, Sumiya T, Takayama T, Takayama Y, Takeda H, Togashi T, Yahata K, Yamada H,
Journal:Nat Methods
PubMed ID:19054851
Appropriate resources and expression technology necessary for human proteomics on a whole-proteome scale are being developed. We prepared a foundation for simple and efficient production of human proteins using the versatile Gateway vector system. We generated 33,275 human Gateway entry clones for protein synthesis, developed mRNA expression protocols for them ... More